noom vs hims glp-1 jumps into off-brand weight loss drug market Noom Eyes GLP-1s for Longevity,

259, no

Current evidence is limited to small-sample clinical observations and animal models, with no large-scale randomized controlled trials (RCTs)

Low dose GLP-1 therapy attenuates pathological cardiac and hepatic remodelling in HFpEF independent of weight loss

Evidence-Based Protein Targets for GLP-1 Users These ranges are consistent with protein recommendations published for weight-loss-phase nutrition and reflect the elevated requirements that accompany both caloric restriction and aging. For practical reference: a 180-pound (82 kg) active adult on a GLP-1 should be targeting approximately 115130 grams of protein per day